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Summary 
Short DNA  sequences have been  identified, originally in  association with  Kaposi's sarcoma 
(KS) biopsies, that are highly homologous to oncogenic, lymphotropic herpesviruses. Recendy 
a virus,  Kaposi sarcoma associated  herpesvirus (KSHV) or human herpesvirus-8 (HHV-8), bear- 
ing these sequences has been identified in a cell line derived from a body cavity-based lymphoma. 
In this report, we show that the same sequences are present in KS biopsies as DNA molecules 
of a form and size characteristia of latent herpesviruses--large, covalendy closed, circular epi- 
somes. The genomes migrate with an apparent size larger than the herpesvirus Epstein-Barr vi- 
rus (172 kb). This form of the viral genome was found in four of four biopsies and three of five 
peripheral blood samples  from KS patients. Linear forms of the viral genome, characteristic of 
viral replication, were not detected in the biopsies, but were present in the peripheral blood of 
three out of five patients. The sequences for KSHV/HHV-8 were also detected in the blood 
of four of five allograft patients and three of five healthy donors without KS suggesting that the 
virus is widespread throughout the human population. 
R 
ecendy,  short  DNA  sequences  with  homology  to 
known  herpesviruses  were  detected  in  the  biopsies 
and  blood  of Kaposi  sarcoma  patients  (1-3).  These  se- 
quences were homologous to the oncogenic, lymphotropic 
herpesviruses Epstein-Barr virus (EBV) and herpesvirus saimiri 
(HVS). This led to speculation that a novel oncogenic her- 
pesvirus, KS-associated herpesvirus (KSHV) or human her- 
pesvirus 8 (HHV-8), had been discovered that might play a 
role in the pathogenesis of KS. Recendy a herpesvirus bear- 
ing these sequences has been identified in cell lines derived 
from a body cavity B cell lyrnphoma (4--6). However, it re- 
mains to be demonstrated that the sequences present in KS 
patients are part of an intact herpesvirus genome. 
Herpesviruses establish  latent infections for the lifetime 
of the  host.  Their large DNA  genomes,  100-250  kb  (7), 
persist extrachromosomally in latently infected cells as co- 
valently closed circles (CCC). The best studied example of 
this is Epstein-Barr virus (EBV) which can maintain a per- 
sistent,  latent infection both in vivo and in vitro as a CCC 
episome (8-10). When the virus is reactivated, it begins to 
produce linear forms of the genome for packaging into vir- 
ions.  The  circular and  linear forms  of herpesviral DNA, 
representing  latent  and  replicative  infection  respectively, 
can be resolved based on differential migration in in situ ly- 
sis agarose gels (Gardella gels) (11,  12). The validity of this 
method has been established previously (11-13).  In a large 
panel  of cell lines  which  either lack  or possess  episomal 
DNA, as judged by restriction enzyme analysis and in situ 
fluorescence hybridization, the  presence  of the  appropri- 
ately migrating DNA on a Gardella gel was consistently di- 
agnostic for the presence or absence ofepisomal DNA (12). 
Furthermore, the conversion of the linear to the episomal 
form, in newly infected cells (13), and episomal to linear by 
double strand nicking (unpublished observations), can both 
be demonstrated with Gardella gels. 
We show that the KSHV DNA sequences in KS biopsies 
migrated in Gardella gels at a position characteristic of the 
large circular DNA molecules detected in latent herpesvirus 
infections, whereas DNA  characteristic of the linear form 
found during viral repfication, was  detected in peripheral 
blood mononuclear cells (PBMC). We have confirmed the 
presence of KSHV sequences in the biopsies and blood of 
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demonstrate that the sequences are frequently present, at a 
lower level, in KS negative allograft and healthy donors. 
Materials and Methods 
Cell Lines and Cells.  B95-8 (American Type Culture Collec- 
tion [ATCC], Rockville, MD) is a marmoset B cell line, latently 
infected with EBV, in which ,-~  of the cells are spontaneously 
replicating the virus. BJAB  (ATCC)  is an EBV-negative B  cell 
tumor line. 
4-ram punch biopsies of cutaneous KS lesions were obtained 
with informed consent from HIV-positive KS patients, attending 
the Oncology Unit at Beth Israel Hospital, following human ex- 
perimental guidelines of the U.S. Department of Health and Hu- 
man Services and of Beth Israel Hospital. Biopsy specimens were 
dissected free of surrounding connective tissue, minced into small 
pieces and digested with 2.5 rag/m1 of trypsin (Difco) and 10 p,g/ml 
of collagenase type  IV  (Sigma Chem.  Co.,  St.  Louis,  MO)  in 
RPMI1640.  The aliquots were pooled and subjected to  Ficoll- 
Hypaque discontinuous gradient centrifugation at 600 g  for  10 
rain. The interface cells were washed, counted and analyzed by 
Gardella gel (11). For the induction of replication, the biopsy cells 
were incubated overnight at 37~  in RPMI 1640  and 10% fetal 
calf serum. 
PBMC  were prepared from heparinized peripheral blood by 
Ficoll-Hypaque discontinuous gradient centrifugation. The  cells 
were then washed and prepared for Gardella gel analysis  as de- 
scribed (13). 
In Situ Lysis Gardella Gels.  Gardella gels  were  performed  as 
described previously (11) with modifications (8, 12). 
DNA PCR Analysis.  Lanes of the gel were excised, cut into 
slices, and analyzed for EBV by PCR as described previously (8, 14). 
Gels containing biopsy material or peripheral blood samples 
from KS patients were soaked in 1% SDS for 15 rain and TBE for 
~45  min  before  further  manipulation.  After  melting  the  gel 
slices,  25-100  ng carrier tRNA was  added to  each.  DNA was 
then  obtained from  the  slices  by  extracting with  phenol  three 
times and chloroform/iso-amyl alcohol (24:1)  one time. 2.5  M 
ammonium  acetate and  100%  ethanol were  used to precipitate 
the DNA. After washing in 70% ethanol and air drying, the DNA 
was solubilized in 50 ~1 HPLC H20 at 4~  overnight. PC1L am- 
plification of the  233-bp  KS330233 KSHV  sequence  was  per- 
formed with 25 p2 of the sample, essentially as described (2), with 
the addition of a hot start and 1 unit of Taq extender (Stratagene 
Inc.,  La Jolla,  CA)  per reaction.  As a  positive control,  cloned 
PCR product, kindly supplied by Dr P. Moore (Cornell Medical 
School), was used. EBV DNA was used as a negative specificity 
control. As negative controls, five samples of 106 BJAB cells and/ 
or five no DNA controls were performed with every set of PCtL 
reactions and a complete Gardella gel analysis was performed on 
BJAB  cells  and PBMC  from an HIV-negative donor who  was 
also  KSHV  negative by  PCR  (Table  1  donor  3).  No  specific 
KSHV PCR product was ever detected in the specificity or nega- 
tive control samples. 
The PCR  products of DNA from sequential slices of a Gar- 
della gel lane were analyzed in two rows of the same gel. In every 
case where photographs are spliced the samples are continuous, 
from the same gel, just different rows from the gel, and from the 
same film and photograph with the same exposure. 
Cloning and Sequencing of the PCR Product.  5 p~l of DNA from 
slices positive for the putative KSHV were subjected to an addi- 
tional 30 cycles of PC1L amplification. The resultant 233 bp prod- 
uct was purified using the Qiaex DNA gel extraction kit (Qiagen, 
Inc.,  Chatsworth,  CA)  or through  electro-elution onto  DEAE 
SSNA 45  paper (Schleicher &  Schuell, Inc., Keene, NH).  The 
TA Cloning Kit (Invitrogen, San Diego, CA) was used to sub- 
clone the purified PCtk products according to manufacturer's in- 
structions  except the  XL-1  blue  strain  of E.  coli was  used  for 
transformation. The presence of an appropriately sized insert was 
verified by digestion of the plasmid DNA with EcoR.I (Pharmacia 
LKB Biotechnology, Inc., Piscataway,  NJ). Double-stranded DNA 
sequencing by the dideoxy method was performed with the Se- 
quenase Version 2.0 kit (United States Biochem.  Corp., Cleve- 
land, OH) using M13 reverse and T7 promoter 23mer as primers 
(New England Biolabs, Beverly, MA). Comparison to the pub- 
lished sequence of KSHV confirmed that we had identified and 
amplified the correct sequence. 
Results 
Analysis by  DNA  PC1K  of biopsies  and  PBMC  from 
HIV-positive KS  patients  confirmed  previous  results  that 
the sequences could be consistently detected in the biopsies 
(Table 1). However, we detected the sequences at a much 
higher frequency (90%) in the PBMC than reported previ- 
ously (56%)  (3).  The  sequences  were  also detected in the 
PBMC from immunosuppressed allogra~ patients and healthy 
donors. To detect the sequences in these individuals it was 
necessary to test multiple samples of 1  X  106 PBMC  (Table 
2),  whereas  106  PBMC  was  always sufficient for  KS  pa- 
tients. Negative control PCR  reactions using the BJAB cell 
line were always tested in parallel and were never positive, 
indicating that the results were not due to contamination. 
Detection of KSHV-assodated Sequences in Large Circular DNA 
Molecules Present in KS Biopsies.  The  in situ lysis/Gardella 
gel technique  can resolve the  circular and linear forms  of 
herpesvirus genomes. This is demonstrated for EBV in Fig. 
1, A  and B. Fig. 1 A  shows a Gardella gel of 106 B95-8 cells 
analyzed by Southern blotting for EBV sequences. Approx- 
imately 5% of the cells are known to be replicating the vi- 
rus at any one time while the remainder of the cells are la- 
tently  infected.  The  resolution  of the  circular and  linear 
forms of the viral DNA can be clearly seen. We have mod- 
ified the Gardella gel technique to detect small numbers of 
EBV infected cells or genomes by performing DNA  PCR 
on sequential slices from the gel (8). Fig. 1 B shows the re- 
sults obtained from analysis of 10 cells from the B95-8  cell 
line. A  signal is  detected  at  the  migration point for both 
Table 1.  Summary of Tissues and Donors Positive  for the 
KSHV Sequences 
No. Donors positive/ 
Tissue  Origin  no. tested 
Biopsy  KS  5/5 
PBMC  KS  8/9 
PBMC  Allograft  4/5 
PBMC  Healthy  3/5 
284  Intact Viral Genome in Blood and Tumors of KS Patients Table 2.  Detailed  Analysis of PBMC  fiom Allografi and 
Healthy Individuals 
No. samples positive*/ 
Origin  Donor  no. tested 
Allograft  1  6/30 
2  0/8 
3  9/10 
4  1/12 
5  1/12 
Healthy  1  1  / 17 
2  1/15 
3  0/10 
4  2/10 
5  0/10 
BJAB  KSHV negative cell line  0/40 
*Each replica contained DNA extracted from 106 PBMC's 
circular and linear forms ofEBV DNA. The signal intensity 
for linear DNA  is much  stronger than  for  circular DNA, 
because  lyrically infected cells have  much  higher  genome 
copy numbers than latently infected cells (15). 
We  have  applied this type of analysis to  cells from four 
KS biopsies, but  with  PC1L amplification for  the  KSHV- 
associated sequences.  The  results are summarized in Table 
3  and shown in detail for one biopsy in Fig. 1  C.  A  PCR 
signal was seen for DNA migrating in the region character- 
istic of circular DNA, but no signal was detected in the re- 
gion  expected for  a  linear form  of a  herpesvirus genome. 
The  KS  DNA  appeared  to  migrate  slower  than  we  have 
observed for EBV.  This  difference could be due  to  varia- 
tion between gels or represent a genuine size difference. To 
assess  this,  we  measured  the  relative  mobility of circular 
EBV  and  KS  DNA,  by loading a  KS  biopsy sample  and 
B95-8  cells in parallel lanes of the same gel (Fig. 2, A  and 
B). This experiment confirmed that the KSHV DNA  does 
migrate  slower than  EBV  suggesting  a  significantly larger 
genome size (11). 
To confirm that the DNA in the biopsies was circular, it 
was  necessary to  demonstrate  that  it would  migrate  faster 
when  in the linear form.  Incubation of Burkitt lymphoma 
biopsies at  37~  results in  reactivation of the  endogenous 
EBV genome to produce infectious virus (16). To generate 
the linear form of the KSHV DNA we attempted to reacti- 
vate  viral  replication  by  incubating  biopsy  specimens  at 
37~  for "~8 h. The DNA from the cells was then analyzed 
in parallel with freshly isolated biopsy cells and B95-8 cells. 
Prior incubation of the biopsy ceils resulted in a  PCR  sig- 
nal being detected at a faster mobility than the circular KS 
or EBV  control DNA,  consistent with  the  migration  ex- 
pected with a linear form of a herpesvirus genome  (Fig. 2, 
C  and D). These experiments demonstrate that the herpes- 
Figure 1.  Gardella  gel analysis  for EBV and KSHV. (.4) Southern blot 
analysis of a Gardella gel on which  106 B95-8  cells were fractionated. 
Cells were lysed in situ, fractionated and analyzed by Southern blotting as 
described previously (12). The gel is shown sideways  for comparison to B 
(below). The top of the gel is indicated. B95-8 is a marmoset cell line that 
contains a mixture of cells latently or lytically infected with EBV. Note 
the resolution obtained between the circular form of the viral genome, 
characteristic  oflatently infected cells, and the linear form characteristic  of 
lytically infected cells. (B) As A but only 10 B95-8 cells, mixed with 106 
EBV-negative BJAB cells as carrier, were loaded on the gel and instead of 
Southern blotting directly, the gel was sliced, DNA extracted from each 
slice, the DNA subjected to PCK and the PCR products analyzed by 
Southern blotting. Vertical lines (/) denote slots of the gel loaded with 
DNA PCK product from each sequential gel sfice.  The slice closest to the 
top and the approximate correlation with A are indicated. The first slice 
of the Gardella gel was not analyzed by PCR. because it was not made 
from low melting agarose to maintain the integrity of the sample well. (C) 
As B except the DNA PCR analysis  was for the putative KSHV sequence 
KS330233 and the cells were from the KS biopsy of patient 1. PCR analy- 
sis was as described (1). Vertical lines (/)  denote analysis for the PCR 
products from each gel slice. (+) is a positive control of cloned PCR 
product and (-) are two negative control lanes (no DNA or 106 BJAB 
cells). 
virus-like sequences in KS can also migrate in the Gardella 
gel system at mobilities diagnostic for the linear form of a 
herpesvirus genome  and suggest that viral reactivation can 
occur  in  culture  although  we  cannot  unequivocally  ex- 
clude  the  possibility that  the  linear forms  of the  viral ge- 
nome  were  generated  by  double  stranded  nicking  rather 
than replication of the circular genomes. 
Circular and Linear Forms of the KSHV DNA Are Found in 
the Peripheral Blood of KS Patients.  DNA  sequences associ- 
ated with the putative KSHV have been detected by PCR 
in  the  peripheral blood of KS  patients  (3).  We  have  ana- 
lyzed the peripheral blood of five KS patients for the pres- 
ence  of circular and linear forms  of the  viral DNA  using 
Gardella gels  and  the  results  are  summarized  in  Table  3. 
Examples of the analysis from two KS patients and an HIV- 
285  Decker et al.  Brief  Definitive Report Table 3.  Summary  of Results Obtained  fiom Gardella Analysis of 
Biopsies and PBMC  fiom KS Patients 
KS Biopsy  PBMC 
Patient#  Episomes  Linear  Episomes  Linear 
KS1 
KS2" 
KS3 
KS4 
KS5* 
KS6 
KS7 
PBMC~ 
m 
m 
m 
+  + 
-  + 
+ 
+  + 
"The PCR. products from this donor were sequenced. See Fig. 4. 
*No KSHV DNA was detected in the unfractionated PI3MC from this 
patient. 
gPBMC from a healthy donor. 
negative donor, who was negative for KSHV by DNA PCR, 
are presented  in  Fig.  3.  We detected  KSHV sequences  in 
Gardella gel analysis of PBMC from four of  the five donors 
tested.  Of these four,  circular DNA was detected  in  three 
(for example Fig. 3, A and B) and linear DNA was detected 
in  three  (for example  Fig.  3  A).  The  presence  of" linear 
KSHV DNA raised  the possibility that active viral replica- 
tion is ongoing in the peripheral blood of at least some KS 
patients.  The  alternative  explanation,  that  the  linear  se- 
quences were derived by double stranded nicking of circu- 
lar  molecules  during  preparation  of the  samples,  was  un- 
likely  because  the  biopsy  materials  were  treated  more 
harshly than the peripheral  blood yet linear DNA was not 
detected in biopsy material. 
It is  possible  to  distinguish  replication  from  nicking  of 
the circular genome by comparing the sequences of the lin- 
ear  and  circular  forms.  If the  linear  DNA  was  derived 
through nicking then the sequence of the linear and circu- 
lar  PCR  products  should  be  the  same.  If,  on  the  other 
hand,  they  are  derived  through  DNA  replication,  the  se- 
quences may vary due to the incorporanon of random er- 
rors  during  this  process.  We  therefore  subcloned  and  se- 
quenced the PCtL products of the linear and circular DNA 
from  the  peripheral  blood  and  biopsy  of the  same  donor 
(Table  3,  Fig.  4).  As  expected,  the  sequences  were  very 
similar  and  only  the  regions  containing  variations  are 
shown. The sequences of one isolate, derived from the cir- 
cular DNA of the  biopsy,  and  two independent  clones of 
the circular DNA from the peripheral  blood were identical 
to each other and showed only a single base change (C  >T 
at position  1033)  compared to the published  sequence.  By 
comparison,  the  sequences  of two  independently  derived 
clones from the linear DNA from peripheral blood showed 
three nacleotide changes (C >T  at position  1033, A  >T  at 
Figure 2.  Relative  mobility of the circular and linear forms of KSHV 
DNA compared to circular EBV DNA. (A) Cells from an EBV infected 
cell line analyzed /'or EBV DI~A. Only the region containing circular 
DNA is shown. (B) Cells from the KS biopsy of  patient no. 2 fractionated 
m ~ parallel lane ofa Gardelh gel and analyzed KSbtV. Only the region 
containing circular DNA is 6hown. {L-3 As B but the cells were preincu- 
bated at 37~  for "~  h to produce linear genomes. (/9) As C but the cells 
were from  patient no. 4. 
position  1044 and  T  >C  at position  1090)  one of which 
was identical to the change seen in the sequences from the 
circular  DNA.  The  observed  differences  in  sequence  be- 
tween  the  linear  and  circular forms demonstrates  that  the 
linear DNA was not derived through nicking of the circu- 
lar DNA. Furthermore,  the presence of the same single nu- 
cleotide change in both  circular and linear DNA is consis- 
tent  with  the  linear  DNA  being derived  by replication  of 
the same genome that gave rise to the circular DNA. 
Discussion 
The results presented here suggest that KSHV, like other 
herpesviruses,  is  prevalent  in  the  human  population.  The 
higher  number  of positive  reactions  found  in  two  of the 
immunosuppressed  individuals  further  raises  the possibility 
that the virus may be reactivated by immunosuppression.  It 
is also apparent that the amount of the DNA sequences de- 
tected by PCtL is considerably higher in the blIV-positive 
KS patients than in the aUograft or healthy donors. This may 
reflect  higher levels  of virus infection before  the  develop- 
286  Intact Viral Genome in Blood and Tumors of KS Patients Figure 3.  Detection  of circular and linear forms of the KSHV DNA in 
the peripheral blood of KS patients. (A) PBMC from KS patient no. 2 
demonstrating the presence of both linear and circular forms of the viral 
genome. (B) PBMC from  KS patient no. 6 demonstrating  the presence of 
circular DNA only. (C) PBMC from a control donor who was both KS 
negative and HIV negative. 
ment of the tumor, due to HIV immunosuppression, or pro- 
duction of virus from tumor sites other than the skin since 
we have not detected viral replication in skin biopsies. 
The Gardella technique  is an in situ  lysis  gel that allows 
the  detection  of linear,  episomal  and  integrated  forms  of 
herpesvirus  DNA  based  on  their  characteristic  migration. 
This  technique  can  therefore  be  used  to  distinguish  cells 
that  are  latently  infected,  containing  episomes,  from  cells 
that are replicating the virus, containing linear forms of the 
genome (8).  Based on this analysis we have found that the 
herpesvirus  like  sequences  in  the  biopsies  and  peripheral 
blood of KS patients  are contained within  large,  episomal, 
covalently closed, circular DNA structures, a genomic form 
characteristic of latent herpesviruses.  This is direct evidence 
that KSHV has an intact herpesvirus genome and rules out 
the possibility that the viral DNA in the biopsies is all inte- 
grated, as has been speculated recently (17). 
In fresh KS biopsy specimens we detected  only the cir- 
cular form of KSHV DNA associated with latent infection. 
We  cannot  exclude  the  possibility  that  an  undetectably 
small fraction of cells is replicating the virus at a low level. 
However,  by  analogy  with  other  herpesviruses,  the  viral 
genome copy number in a cell replicating the virus should 
be  much  higher,  therefore  easier to detect,  than  a  latendy 
infected cell. For example,  B95-8 cells replicating EBV in 
vitro  have  several  thousand  copies  of the  viral  DNA  (15) 
whereas htendy infected cells in vivo only have 2-5 copies 
(14)  (see for example Fig.  1 B). The fact that we detect cir- 
cular  not  linear  DNA,  therefore  allows  us  to  safely  con- 
clude  that  most of the  infected  cells  are  latently  infected. 
The  lack  of viral  rephcation  explains  why  viral  particles 
have  not  been  readily  detected  in  KS  biopsies.  The  pre- 
dominance ofhtently infected cells with low genome copy 
numbers  also explains  why PCR  amplification  is  required 
to  detect KSHV sequences  by both  in situ  PCR  (18)  and 
Gardella gels. 
One  alternative  interpretation  of our  results  is  that  the 
circular episomes in biopsy material are present in infiltrat- 
ing PBMCs. However, this explanation  is unlikely because 
we have demonstrated that PBMC contain linear genomes, 
but  have  not  detected  linear  genomes  in  biopsy  material 
and  Boshoff et  al.  have  used  in  situ  PCtL  to  demonstrate 
that  the  KSHV-associated  sequences  are  in  the  KS  tumor 
ceils (18). 
We have found evidence  for viral  replication  occurring 
in  the  peripheral  blood mononuclear  cells  of KS patients. 
This  conclusion  is  based  upon  the  finding  that  linear  ge- 
nomes were detected and that they had different sequences 
from the  circular forms found in the blood.  Retrospective 
analysis of the patients we had studied revealed that the one 
individual with plentiful circular DNA, but no linear DNA, 
in the  PBMC was the only patient  to be currently treated 
with the drug ganciciovir which acts by inhibiting the rep- 
lication ofherpesvirus DNA. This coincidence raises the pos- 
sibility that the KSHV may be susceptible to ganciclovir. 
Our experiments do not address the question of whether 
KSHV-HHV8 plays a causal role in the pathogenesis of KS 
itself.  The KS-associated herpesvirus shows highest levels of 
DNA  sequence  homology to  lymphotropic  herpesviruses 
and is found in B  lymphocytes (19).  EBV is highly B lym- 
photropic  yet it  is  present  in  and  causally  associated  with 
1031  1091 
GA  CCCCGTGTTC  CCCATGGTCG  TGCCGCAGCA  ACTGGGGCAC  GCTATTCTGC  AGCAGCTGTT  GGTG 
BIo.  Circ.--  --t  ............................................................. 
PBL  CIrc.--  --t  ............................................................. 
....  t  ............................................................. 
PBL  LIn.  --  --t  ..........  t  .............................................  c  .... 
....  t  ..........  t  .............................................  0  .... 
Figure 4.  Sequence  analysis of 
KSHV from the PBMC and tu- 
mor biopsy. Each sequence was 
derived from an  independently 
isolated clone of PCR  product 
from the same donor (see legend 
to Table 2). The top line is the 
published sequence for KS330z33 
(1) and the numbers refer to the 
nucleotide  numbering used  in 
that  reference.  The  sequences 
below are our aligned sequences showing only the region that differed from the published sequence. (Bio. Circ.) Circular DNA from the KS biopsy. (PBL 
Circ.) Circular DNA from the PBMC. 
287  Decker et al.  BriefDefimtive Report the  development  of non-lymphoid  tumors  especially the 
epithelial cell  tumor  nasopharyngeal  carcinoma.  By  anal- 
ogy,  the  KS  herpesvirus  may  also  be  lymphotropic  and 
normally  benign  in  these  cells,  but  becomes  oncogenic 
when  it inappropriately gains access to  the precursor cells 
for KS. 
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